Original Research

Published on 30 May 2024

Mechanism of isorhynchophylline in lipopolysaccharide-induced acute lung injury based on proteomic technology

in Inflammation Pharmacology

Yaru Li
Junfeng Xing
Ling Qin
Chuanming Zhang
Zheng Yang
Min Qiu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1397498

795 views

Review

Published on 30 May 2024

Recommendations for nutritional supplements for dry eye disease: current advances

in Inflammation Pharmacology

Ying Cong
Yibing Zhang
Yutong Han
Yunlong Wu
Dan Wang
Bingjie Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1388787

2,928 views
1 citation

Original Research

Published on 28 May 2024

Sitagliptin ameliorates L-arginine-induced acute pancreatitis via modulating inflammatory cytokines expression and combating oxidative stress

in Inflammation Pharmacology

Heba M. Eltahir
Hossein M. Elbadawy
Mohannad A. Almikhlafi
Ali M. Alalawi
Ahmed J. Aldhafiri
Yaser M. Alahmadi
Sultan S. Al thagfan
Muayad Albadrani
Saber M Eweda
Mekky M. Abouzied

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389670

1,375 views
1 citation

Review

Published on 21 May 2024

The role of inflammation in central serous chorioretinopathy: From mechanisms to therapeutic prospects

in Inflammation Pharmacology

Xiao Shen
Fanhua Kong
Jing Wen
Xiao Wang
Chunlian Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1200492

1,439 views

Editorial

Published on 17 May 2024

Editorial: Anti-inflammatory drug development focusing on immune mediated diseases

in Inflammation Pharmacology

José Fernando Oliveira-Costa
Amit Prasad

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413141

783 views

Review

Published on 17 May 2024

Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology

in Inflammation Pharmacology

Xiao Xiao Li
Maierhaba Maitiyaer
Qing Tan
Wen Hui Huang
Yu Liu
Zhi Ping Liu
Yue Qiang Wen
Yu Zheng
Xing Chen
Rui Lin Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377055

2,403 views
3 citations

Review

Published on 16 May 2024

Potential use of antioxidants for the treatment of chronic inflammatory diseases

in Inflammation Pharmacology

Alexander V. Blagov
Volha I. Summerhill
Vasily N. Sukhorukov
Elena B. Zhigmitova
Anton Y. Postnov
Alexander N. Orekhov

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1378335

2,393 views
3 citations

Original Research

Published on 14 May 2024

Hedgehog signaling is a promising target for the treatment of hepatic fibrogenesis: a new management strategy using itraconazole-loaded nanoparticles

in Inflammation Pharmacology

Elsayed A. Elmorsy
Sameh Saber
Ahmed Y. Kira
Abdullah Alghasham
Mohamed R. Abdel-Hamed
Maha M. Amer
Enas A. Mohamed
A AlSalloom A.
Abdullah S. Alkhamiss
Rabab S. Hamad

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377980

1,608 views
2 citations

Original Research

Published on 10 May 2024

Lobetyolin protects mice against LPS-induced sepsis by downregulating the production of inflammatory cytokines in macrophage

in Inflammation Pharmacology

Zhonghua Chen
Yixin Su
Jingtong Ding
Jia He
Lihua Lai
Yinjing Song

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1405163

1,552 views
3 citations

Review

Published on 10 May 2024

Inflammation and cancer: friend or foe?

in Inflammation Pharmacology

Andrés David Turizo-Smith
Samantha Córdoba-Hernandez
Lidy Vannessa Mejía-Guarnizo
Paula Stefany Monroy-Camacho
Josefa Antonia Rodríguez-García

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1385479

4,124 views
4 citations

Original Research

Published on 29 Apr 2024

Bergamottin (Ber) ameliorates the progression of osteoarthritis via the Sirt1/NF-κB pathway

in Inflammation Pharmacology

Guangjie Shen
Weihao Zhang
Qiming Tu
Juncheng Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1389786

1,144 views

Review

Published on 24 Apr 2024

Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: a systematic review and network meta-analysis of randomized controlled trials

in Inflammation Pharmacology

Wenting Cai
Rui Tong
Yue Sun
Yao Yao
Jinping Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1387585

3,953 views

Review

Published on 10 Apr 2024

Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?

in Inflammation Pharmacology

Diana V. Ávila-Martínez
Wendy K. Mixtega-Ruiz
José M. Hurtado-Capetillo
Oscar Lopez-Franco
Mónica Flores-Muñoz

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1377113

1,340 views
1 citation

Systematic Review

Published on 10 Apr 2024

Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis

in Inflammation Pharmacology

Ting Yan
Ting Wang
Mei Tang
Nan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1372810

4,320 views
1 citation

Original Research

Published on 09 Apr 2024

Assessing the impact of body composition, metabolic and oxidative stress parameters on insulin resistance as a prognostic marker for reactive hypoglycemia: a cross-sectional study in overweight, obese, and normal weight individuals

in Inflammation Pharmacology

Maria Kościuszko
Angelika Buczyńska
Katarzyna Łuka
Ewa Duraj
Katarzyna Żuk-Czerniawska
Agnieszka Adamska
Katarzyna Siewko
Aleksandra Wiatr
Adam Jacek Krętowski
Anna Popławska-Kita

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1329802

847 views

Editorial

Published on 05 Apr 2024

Editorial: Targeting immune cell metabolism in tissue fibrosis

in Inflammation Pharmacology

Dan Shan
Qianjiang Hu
Chao He
Yong Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1400858

648 views

Navigation group

Articles

Mechanism of isorhynchophylline in lipopolysaccharide-induced acute lung injury based on proteomic technology

Recommendations for nutritional supplements for dry eye disease: current advances

Sitagliptin ameliorates L-arginine-induced acute pancreatitis via modulating inflammatory cytokines expression and combating oxidative stress

The role of inflammation in central serous chorioretinopathy: From mechanisms to therapeutic prospects

Editorial: Anti-inflammatory drug development focusing on immune mediated diseases

Emerging biologic frontiers for Sjogren’s syndrome: Unveiling novel approaches with emphasis on extra glandular pathology

Potential use of antioxidants for the treatment of chronic inflammatory diseases

Hedgehog signaling is a promising target for the treatment of hepatic fibrogenesis: a new management strategy using itraconazole-loaded nanoparticles

Lobetyolin protects mice against LPS-induced sepsis by downregulating the production of inflammatory cytokines in macrophage

Inflammation and cancer: friend or foe?

Bergamottin (Ber) ameliorates the progression of osteoarthritis via the Sirt1/NF-κB pathway

Comparative efficacy of five approved Janus kinase inhibitors as monotherapy and combination therapy in patients with moderate-to-severe active rheumatoid arthritis: a systematic review and network meta-analysis of randomized controlled trials

Counter-regulatory RAS peptides: new therapy targets for inflammation and fibrotic diseases?

Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis

Assessing the impact of body composition, metabolic and oxidative stress parameters on insulin resistance as a prognostic marker for reactive hypoglycemia: a cross-sectional study in overweight, obese, and normal weight individuals

Editorial: Targeting immune cell metabolism in tissue fibrosis